Jason Fuller

Jason Fuller

Corporate Officer/Principal bei
Massachusetts Institute of Technology
48 Jahre
Health Technology
Finance
Consumer Services

Profil

Jason Fuller, Ph.D., is a Partner on the Therapeutics team and joined the Firm in 2021.
Prior to Deerfield, Dr. Fuller was an investor at New Enterprise Associates (NEA), where he co-managed several investments in therapeutics, as well as in tools and diagnostics.
Previous to NEA, he served as Head of Corporate Development at Jounce Therapeutics, one of several company formation projects he helped initiate in his role as Principal at Third Rock Ventures before joining Jounce.
Dr. Fuller holds a B.S.
in Chemical Engineering from Michigan State University, an M.Phil.
from Cambridge University, and a Ph.D.
in Chemical Engineering from the Massachusetts Institute of Technology, where he completed his degree in the lab of Robert Langer

Aktive Positionen von Jason Fuller

UnternehmenPositionBeginn
Corporate Officer/Principal 07.04.2011
Private Equity Investor 01.01.2014
Private Equity Investor 01.01.2021

Ehemalige bekannte Positionen von Jason Fuller

UnternehmenPositionEnde
GALERA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 09.06.2020
Direktor/Vorstandsmitglied -
JOUNCE THERAPEUTICS, INC. Gründer -
SAGIMET BIOSCIENCES INC. Direktor/Vorstandsmitglied -
3M COMPANY Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Jason Fuller im Detail an

Ausbildung von Jason Fuller

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

97

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Finance

Health Technology

Health Technology

Finance

  1. Börse
  2. Insiders
  3. Jason Fuller